Perrine Rochas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Perrine Rochas has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Caroline Plazy
CDiReC, Pôle Biologie, Centre Hospitalier Universitaire Grenoble Alpes, 38043 Grenoble, France
2 shared publications - Franck Fieschi
Université Grenoble Alpes
2 shared publications - Isabelle Petit-Härtlein
Institut de Biologie Structurale, UMR5075, CNRS, CEA, Université Grenoble Alpes, 38042 Grenoble, France
2 shared publications - Maria Val-Pevida
Institut de Biologie Structurale, UMR5075, CNRS, CEA, Université Grenoble Alpes, 38042 Grenoble, France
2 shared publications - Marie José Stasia
Centre Diagnostic et Recherche CGD (CDiReC), Pôle Biologie, CHU Grenoble Alpes, Grenoble, France.
2 shared publications - Sylvain Beaumel
CDiReC, Pôle Biologie, Centre Hospitalier Universitaire Grenoble Alpes, 38043 Grenoble, France
2 shared publications
Latest Publications
- Open Access
- 6 June 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (6) , 724
Molecular Views into the Synthesis and Activation of Flavocytochrome b558 in Phagocytic Cells—Focus on the Role of EROS
Recent advances in the structural characterization of the phagocyte NADPH oxidase coupled with the description of its chaperone EROS for Essential for Reactive Oxygen Species have led to a better understanding of its function and activation in phagocytic cells. This review examines the role of EROS chaperone in flavocytochrome b558 biosynthesis and function and in physiological and pathological conditions. Based on experimental data and structural insights, we synthesize knowledge from former work on flavocytochrome b558 synthesis and structure combined with recent advances on the specific role of EROS chaperone on the potential control of Reactive Oxygen Species (ROS) production by c flavocytochrome b558. We particularly emphasize its role in the pathological context of Chronic Granulomatous Disease (CGD), with already described EROS mutations (known as CGD5), as well as rare X91minus-CGD (or X91−-CGD) cases characterized by low flavocytochrome b558 expression in phagocytes that could be due to a lack of interaction with EROS. Future works should address in more detail how EROS binding and release from flavocytochrome b558 is regulated, and whether the inhibitory effect on ROS production that was observed in EROS overexpression studies is relevant in a more physiological context.
- 6 June 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (6) , 724
Open AccessMolecular Views into the Synthesis and Activation of Flavocytochrome b558 in Phagocytic Cells—Focus on the Role of EROS
Recent advances in the structural characterization of the phagocyte NADPH oxidase coupled with the description of its chaperone EROS for Essential for Reactive Oxygen Species have led to a better understanding of its function and activation in phagocytic cells. This review examines the role of EROS chaperone in flavocytochrome b558 biosynthesis and function and in physiological and pathological conditions. Based on experimental data and structural insights, we synthesize knowledge from former work on flavocytochrome b558 synthesis and structure combined with recent advances on the specific role of EROS chaperone on the potential control of Reactive Oxygen Species (ROS) production by c flavocytochrome b558. We particularly emphasize its role in the pathological context of Chronic Granulomatous Disease (CGD), with already described EROS mutations (known as CGD5), as well as rare X91minus-CGD (or X91−-CGD) cases characterized by low flavocytochrome b558 expression in phagocytes that could be due to a lack of interaction with EROS. Future works should address in more detail how EROS binding and release from flavocytochrome b558 is regulated, and whether the inhibitory effect on ROS production that was observed in EROS overexpression studies is relevant in a more physiological context.
- Open Access
- 27 May 2026
- Published by MDPI AG in Preprints.org
Molecular Views onto the Synthesis and Activation of Cytochrome b558 in Phagocytic Cells—Focus on the Role of EROS
Recent advances in the structural characterization of the phagocyte NADPH oxidase coupled to the description of its chaperone EROS for Essential for Reactive Oxygen Species have led to a better understanding of its function and activation in phagocytic cells. This review examines the role of EROS chaperone in cytochrome b558 biosynthesis and function, in physiological and pathological conditions. Based on experimental data and structural insights, we synthesize knowledge from former work on cytochrome b558 synthesis and structure combined with recent advances on the specific role of EROS chaperone on the potential control of Reactive Oxygen Species (ROS) production by cytochrome b558. We particularly emphasize its role in the pathological context of Chronic Granulomatous Disease (CGD), with already described EROS mutations (known as CGD5), as well as rare Xminus-CGD cases characterized by low cytochrome b558 expression in phagocytes that could be due to a lack of interaction with EROS. Future works should address in more details how EROS binding and release from cytochrome b558 is regulated, and whether the inhibitory effect on ROS production that was observed in EROS overexpression studies is relevant in a more physiological context.
- 27 May 2026
- Published by MDPI AG in Preprints.org
Open AccessMolecular Views onto the Synthesis and Activation of Cytochrome b558 in Phagocytic Cells—Focus on the Role of EROS
Recent advances in the structural characterization of the phagocyte NADPH oxidase coupled to the description of its chaperone EROS for Essential for Reactive Oxygen Species have led to a better understanding of its function and activation in phagocytic cells. This review examines the role of EROS chaperone in cytochrome b558 biosynthesis and function, in physiological and pathological conditions. Based on experimental data and structural insights, we synthesize knowledge from former work on cytochrome b558 synthesis and structure combined with recent advances on the specific role of EROS chaperone on the potential control of Reactive Oxygen Species (ROS) production by cytochrome b558. We particularly emphasize its role in the pathological context of Chronic Granulomatous Disease (CGD), with already described EROS mutations (known as CGD5), as well as rare Xminus-CGD cases characterized by low cytochrome b558 expression in phagocytes that could be due to a lack of interaction with EROS. Future works should address in more details how EROS binding and release from cytochrome b558 is regulated, and whether the inhibitory effect on ROS production that was observed in EROS overexpression studies is relevant in a more physiological context.